Ikena Oncology | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Regulatory Trial results

29 May 2024

Ikena rolls over on Hippo

Trial results

10 November 2023

Nothing like Hippo for cooling investor enthusiasm

Ikena is savaged in a bear market after reporting zero remissions in a dose-escalation trial of its lead asset.

Subscribe to Ikena Oncology